Your browser doesn't support javascript.
loading
Intensive care treatment in acute pulmonary embolism in Germany, 2016 to 2020: a nationwide inpatient database study.
Keller, Karsten; Sagoschen, Ingo; Farmakis, Ioannis T; Mohr, Katharina; Valerio, Luca; Wild, Johannes; Barco, Stefano; Schmidt, Frank P; Gori, Tommaso; Espinola-Klein, Christine; Münzel, Thomas; Lurz, Philipp; Konstantinides, Stavros; Hobohm, Lukas.
Afiliación
  • Keller K; Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Sagoschen I; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Farmakis IT; Medical Clinic VII, Department of Sports Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Mohr K; Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Valerio L; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Wild J; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Barco S; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
  • Schmidt FP; Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Gori T; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Espinola-Klein C; Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Münzel T; Department of Internal Medicine, University Clinic Gießen and Marburg, Marburg, Germany.
  • Lurz P; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Konstantinides S; Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Hobohm L; Department of Cardiology, Mutterhaus Trier, Trier, Germany.
Res Pract Thromb Haemost ; 8(6): 102545, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39318771
ABSTRACT

Background:

Pulmonary embolism (PE) is a potentially life-threatening condition. Admission and treatment in the intensive care unit (ICU) is an important element in critically ill PE patients.

Objectives:

We aimed to identify risk factors for ICU admission and differences in patient profiles regarding risk factors and comorbidities between PE patients who had to be admitted to an ICU and those who were treated in a normal ward without ICU.

Methods:

We used the German nationwide inpatient sample to analyze all hospitalizations of PE patients in Germany from 2016 to 2020 stratified for ICU admission.

Results:

Overall, 484,859 hospitalized PE patients were treated in German hospitals from 2016 to 2020. Among these, 92,313 (19.0%) were admitted to ICU. Patients treated in ICU were younger (69.0 [IQR, 58.0-78.0] vs 72.0 [IQR, 60.0-80.0] years; P < .001) and had higher prevalence of cardiovascular risk factors and comorbidities. In-hospital case fatality rate was elevated in PE patients treated in ICU (22.7% vs 10.7%; P < .001), and ICU admission was independently associated with increased in-hospital case fatality (odds ratio [OR], 2.54; 95% CI, 2.49-2.59; P < .001). Independent risk factors for ICU admission comprised PE with imminent or present decompensation (OR, 3.30; 95% CI, 3.25-3.35; P < .001), hemodynamic instability (OR, 4.49; 95% CI, 4.39-4.59; P < .001), arterial hypertension (OR, 1.20; 95% CI, 1.18-1.22; P < .001), diabetes mellitus (OR, 1.16; 95% CI, 1.14-1.18; P < .001), obesity (OR, 1.300; 95% CI, 1.27-1.33; P < .001), surgery (OR, 2.55; 95% CI, 2.50-2.59; P < .001), stroke (OR, 2.86; 95% CI, 2.76-2.96; P < .001), pregnancy (OR, 1.45; 95% CI, 1.21-1.74; P < .001), heart failure (OR, 1.74; 95% CI, 1.71-1.77; P < .001), atrial fibrillation/flutter (OR, 1.69; 95% CI, 1.66-1.73; P < .001), chronic obstructive pulmonary disease (OR, 1.21; 95% CI, 1.18-1.24; P < .001), and renal failure (OR, 1.92; 95% CI, 1.88-1.95; P < .001).

Conclusion:

ICU treatment is an important element in the treatment of PE patients. Besides hemodynamic compromise, cardiovascular risk factors, stroke, pregnancy, and cardiopulmonary as well as renal comorbidities were independent predictors of ICU admission. Necessity of ICU admission was afflicted by increased case fatality.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Res Pract Thromb Haemost Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Res Pract Thromb Haemost Año: 2024 Tipo del documento: Article País de afiliación: Alemania
...